Arima Yoshimi, Inoue Yasumichi, Shibata Tatsuhiro, Hayashi Hidemi, Nagano Osamu, Saya Hideyuki, Taya Yoichi
Radiobiology Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.
The retinoblastoma tumor suppressor protein (Rb) is mutated or expressed at very low levels in several tumor types, including retinoblastoma and osteosarcoma, as well as small cell lung, colon, prostate, bladder, and breast carcinomas. Loss or reduction of Rb expression is seen most commonly in high-grade breast adenocarcinomas, suggesting that a relationship may exist between loss of Rb function and a less-differentiated state, increased proliferation, and high metastatic potential. In this study, we found that knockdown of Rb by small interfering RNA in MCF7 breast cancer cells disrupts cell-cell adhesion and induces a mesenchymal-like phenotype. The epithelial-to-mesenchymal transition (EMT), a key event in embryonic morphogenesis, is implicated in the metastasis of primary tumors. Additionally, Rb is decreased during growth factor- and cytokine-induced EMT and overexpression of Rb inhibits the EMT in MCF10A human mammary epithelial cells. Ectopic expression and knockdown of Rb resulted in increased or reduced expression of E-cadherin, which is specifically involved in epithelial cell-cell adhesion. Other EMT-related transcriptional factors, including Slug and Zeb-1, are also induced by Rb depletion. Furthermore, we confirmed that Rb binds to an E-cadherin promoter sequence in association with the transcription factor activator protein-2alpha. Finally, in breast cancer specimens, we observed a concurrent down-regulation of Rb and E-cadherin expression in mesenchymal-like invasive cancers. These findings suggest that Rb inactivation contributes to tumor progression due to not only loss of cell proliferation control but also conversion to an invasive phenotype and that the inhibition of EMT is a novel tumor suppressor function of Rb.
视网膜母细胞瘤肿瘤抑制蛋白(Rb)在包括视网膜母细胞瘤、骨肉瘤以及小细胞肺癌、结肠癌、前列腺癌、膀胱癌和乳腺癌在内的多种肿瘤类型中发生突变或表达水平极低。Rb表达缺失或降低在高级别乳腺腺癌中最为常见,这表明Rb功能丧失与低分化状态、增殖增加以及高转移潜能之间可能存在关联。在本研究中,我们发现通过小干扰RNA敲低MCF7乳腺癌细胞中的Rb会破坏细胞间黏附并诱导间充质样表型。上皮-间质转化(EMT)是胚胎形态发生中的关键事件,与原发性肿瘤的转移有关。此外,在生长因子和细胞因子诱导的EMT过程中Rb水平降低,而Rb的过表达抑制MCF10A人乳腺上皮细胞中的EMT。Rb的异位表达和敲低导致E-钙黏蛋白表达增加或减少,E-钙黏蛋白专门参与上皮细胞间黏附。其他与EMT相关的转录因子,包括Slug和Zeb-1,也由Rb缺失诱导产生。此外,我们证实Rb与转录因子激活蛋白-2α结合至E-钙黏蛋白启动子序列。最后,在乳腺癌标本中,我们观察到在间充质样浸润性癌中Rb和E-钙黏蛋白表达同时下调。这些发现表明,Rb失活不仅由于细胞增殖控制丧失,还由于向侵袭性表型的转变而导致肿瘤进展,并且抑制EMT是Rb的一种新的肿瘤抑制功能。